![](/img/cover-not-exists.png)
361O Patient-reported outcomes (PROs) in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN) treated with nivolumab (Nivo) or Investigator’s Choice (IC): CheckMate 141
Kiyota, N., Harrington, K., Ferris, R.L., Shaw, J.W., Taylor, F., Derosa, M., Turner-Bowker, D., Morrissey, L., Cocks, K., Gillison, M., Guigay, J.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw587.003
Date:
December, 2016
File:
PDF, 42 KB
english, 2016